Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Will State Street Corporation (STT) Increase Its Dividend?

Last week, the Federal Reserve released the first part of the annual banking stress test results, which examined the impact of a severe economic downturn on the largest U.S. banks. While it stood out as one of the strongest banks during last year’s stress tests, State Street Corporation (NYSE:STT) again posted especially encouraging results. The results highlighted the strength and sustainability of State Street’s institutional client-focused business.

State Street CorporationHow it fared last week
In addition to posting a higher actual Tier 1 common ratio in Q3 in 2012 compared to 2011, State Street Corporation (NYSE:STT) posted an impressive minimum Tier 1 common ratio of 12.8% under the severely adverse scenario. During the previous year’s tests, State Street Corporation (NYSE:STT)’s minimum Tier 1 common in the doom-and-gloom scenario was a staggering 15.1% without its proposed 33% dividend increase included. This year’s test assumed that elevated dividend remained constant through the nine-quarter stress period, making the 12.8% ratio equally impressive. Regardless of some investors clamoring about the ease of the tests this year, it’s hard to deny State Street Corporation (NYSE:STT)’s balance sheet strength and business prospects.

These strong results have driven investors to tune into the Comprehensive Capital Analysis and Review results, which will be released on Thursday afternoon. Within this release from the Fed, investors will know if the participating banks sought and received approval for any increases in dividends or share buyback programs. Investors will also get to see the impact of any new capital plans on stressed ratios.

Source: Dodd-Frank Act Stress Test 2013: Supervisory Stress Test Methodology and Results.

Should State Street Corporation (NYSE:STT) request another bump?
Last year, State Street Corporation (NYSE:STT) asked and received approval for a 33% increase of quarterly dividend payments. Additionally, the Fed did not reject the company’s proposal for a new common stock repurchase program authorizing the purchase of up to $1.8 billion of stock though Q1 2013. State Street Corporation (NYSE:STT) ultimately repurchased 33.4 million shares of common stock in 2012 for roughly $1.44 billion, almost $1 billion more than it distributed in the form of common stock dividends. Given the substantial improvement of its balance sheet under a stressed scenario, State Street Corporation (NYSE:STT) seems to have ample leverage in negotiating any additional actions to return more cash to shareholders.

How much?
State Street is strong enough to request a substantial increase in dividend, and I believe investors are anticipating a dividend increase and additional stock buyback capacity. The Fed has explicitly said that dividend payout ratios above 30% will receive “particularly close scrutiny.” State Street’s dividend payout ratio was around 22.5% in 2012, suggesting room for growth. If the Fed and the bank cannot agree on a substantial dividend increase, State Street will likely request an increase of share repurchases, which was its more significant capital action plan in 2012.

The article Will State Street Increase Its Dividend? originally appeared on

David Hanson has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!